The Therapeutic Goods Administration is experiencing system issues linked to global Microsoft outages. Some services may be disrupted and we may take longer to respond to email and phone contact during this time.
OLMESARTAN GxP, OLMESARTAN GPPL, OLMES, OLMESART (Generic Partners Pty Ltd)
Product name
OLMESARTAN GxP, OLMESARTAN GPPL, OLMES, OLMESART
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
138 working days (255)
Active ingredients
olmesartan medoxomil
Registration type
New generic medicine
Indication
OLMESARTAN GxP, OLMESARTAN GPPL, OLMES, OLMESART (tablets) is indicated for the treatment of hypertension.